Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation

Warren van Loggerenberg1, Shahin Sowlati-Hashjin2, Jochen Weile1

  • 1Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada; Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON M5G 1X5, Canada; Department of Computer Science, University of Toronto, Toronto, ON M5S 2E4, Canada.

PubMed
Summary

Researchers developed a new method to assess the function of hydroxymethylbilane synthase (HMBS) variants, aiding in the diagnosis of acute intermittent porphyria (AIP). This approach helps distinguish between harmful and harmless HMBS gene mutations for better patient outcomes.